Fig. 2. Proportions of reported adverse events in ChAdOx1 nCoV-19 vaccine recipients stratified by age (A). Positive responses rates of each adverse events in ChAdOx1 nCoV-19 vaccine recipients on post-vaccination days 0–7 (B).

^*P < 0.05; ^**P < 0.005.